<DOC>
	<DOCNO>NCT00097669</DOCNO>
	<brief_summary>The VITATOPS study multi-center , randomize , double blind , placebo-controlled secondary stroke prevention trial determine whether addition vitamin supplement ( B12 500 ug , B6 25 mg , Folate 2 mg ) best medical/surgical management ( include modification risk factor ) reduce combine incidence recurrent vascular event ( stroke , myocardial infarction ) vascular death patient recent stroke transient ischemic attack ( TIA ) . All patient present one participate neurologist general physician within seven month stroke ( ischemic hemorrhagic ) TIA ( eye brain ) eligible trial . Eligible patient randomize double-blind fashion receive multi-vitamins placebo , 1 tablet daily . The primary outcome event composite event `` stroke , myocardial infarction , death vascular cause '' , whichever occur first . Our target recruit total 8,000 patient next two year median follow-up 2.5 year . Recruitment trial begin November 1998 plan continue December 2005 . We aim complete final follow-up end 2006 . However , Steering Committee flexible dictate need ongoing recruitment continue follow-up , depend overall rate primary outcome event entire cohort interim analysis .</brief_summary>
	<brief_title>VITATOPS : A Study VITAmins TO Prevent Stroke</brief_title>
	<detailed_description>Background : Epidemiological study suggest raise plasma concentration total homocysteine ( tHcy ) may common , causal treatable risk factor atherothromboembolic ischemic stroke , dementia depression . Although tHcy lower effectively small dos folic acid , vitamin B12 vitamin B6 , know whether lower tHcy , mean multivitamin therapy , prevent stroke major atherothromboembolic vascular event , dementia depression . Purpose : To determine whether vitamin supplement ( folic acid 2 mg , B6 25 mg , B12 500 ug ) reduce risk stroke , serious vascular event , dementia depression patient recent stroke transient ischemic attack brain eye ( TIA ) . Methods : An international , multi-center , randomize , double-blind , placebo-controlled clinical trial . Subjects : Patients stroke TIA previous 7 month . Primary outcome measure : Non-fatal stroke , non-fatal myocardial infarction , death due vascular cause . Secondary outcome measure : TIA , Revascularisation procedures , Dementia , Depression . Sample size calculation : To reliably identify 15 % reduction relative risk primary outcome event 8 % 6.8 % per year alpha 0.05 power 80 % , 8,000 patient need randomize followed-up average two year . Current progress : As November , 2004 , 4,400 patient randomize 73 center 19 country five continent : Australia , Austria , Belgium , Brazil , Hong Kong , Italy , Malaysia , Moldova , Netherlands , New Zealand , Pakistan , Philippines , Portugal , Republic Georgia , Serbia &amp; Monte Negro , Singapore , Sri Lanka , United Kingdom , United States . VITATOPS aim recruit follow 8,000 patient 2000 2006 , provide reliable estimate safety effectiveness dietary supplementation folic acid , vitamin B12 , vitamin B6 reduce recurrent serious vascular event , dementia depression among wide range patient stroke TIA .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemic Attack , Transient</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin B 12</mesh_term>
	<mesh_term>Hydroxocobalamin</mesh_term>
	<mesh_term>Vitamin B 6</mesh_term>
	<mesh_term>Pyridoxal</mesh_term>
	<mesh_term>Pyridoxine</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>Patients present within seven month stroke ( ischemic hemorrhagic ) TIA Agree take study medication Be geographically accessible followup Provide write informed consent Taking folic acid B6 medical advice Use vitamin supplement contain folate , B6 B12 ( unless patient agrees take study medication instead vitamin supplement usually take ) Taking Methotrexate reason Pregnancy woman childbearing potential risk pregnancy Limited life expectancy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>VITATOPS</keyword>
	<keyword>stroke</keyword>
	<keyword>prevention</keyword>
	<keyword>multivitamin</keyword>
	<keyword>homocysteine</keyword>
</DOC>